Disclosed is a method for the treatment of chronic kidney diseases in cats, comprising administering the non-steroidal anti-inflammatory drug (NSAID) meloxicam, or a pharmacologically acceptable salt thereof, wherein the treatment is a long term treatment over 6 to 40 months.